Inventor · disambiguated record
Thierry Dervieux
Also filed as: DERVIEUX THIERRY
13 granted patents·21 pending applications·79 citations·filing 2002–2024
91Inventor score
Files withEXAGEN INC10PROMETHEUS LAB INC9DERVIEUX THIERRY7EXAGEN DIAGNOSTICS INC3CYPRESS BIOSCIENCE INC2
Top patents by PatentIndex Score
34 records- 0195US11885812B2Methods for diagnosing systemic lupus erythematosusEXAGEN INC·Filed 2023·Granted Jan 30, 2024·3 cites·19 claims
- 0295US11761965B2Methods for diagnosing systemic lupus erythematosusEXAGEN INC·Filed 2023·Granted Sep 19, 2023·5 cites·9 claims
- 0395US9261509B2Methods for monitoring methotrexate therapyDERVIEUX THIERRY·Filed 2011·Granted Feb 16, 2016·26 cites·22 claims
- 0493US11360099B2Methods for diagnosing systemic lupus erythematosusEXAGEN INC·Filed 2018·Granted Jun 14, 2022·7 cites·2 claims
- 0589US10132813B2Methods for diagnosing systemic lupus erythematosusDERVIEUX THIERRY·Filed 2012·Granted Nov 20, 2018·8 cites·6 claims
- 0687US12372535B2Methods for diagnosing systemic lupus erythematosusEXAGEN INC·Filed 2024·Granted Jul 29, 2025·0 cites·10 claims
- 0787US7695908B2Methods for predicting methotrexate polyglutamate levels using pharmacogeneticsPROMETHEUS LAB INC·Filed 2005·Granted Apr 13, 2010·5 cites·20 claims
- 0883US11531033B2Methods for treating and diagnosing systemic lupus erythematosusEXAGEN INC·Filed 2014·Granted Dec 20, 2022·4 cites·14 claims
- 0979US12449427B2Methods for treating and diagnosing systemic lupus erythematosusEXAGEN INC·Filed 2022·Granted Oct 21, 2025·0 cites·14 claims
- 1079US2022276259A1Methods for diagnosing systemic lupus erythematosusEXAGEN INC·Filed 2022·Application pending·0 cites
- 1178US6921667B2Methods for direct detection of individual methotrexate metabolitesPROMETHEUS LAB INC·Filed 2003·Granted Jul 26, 2005·13 cites·77 claims
- 1277US2023228768A1Methods for treating and diagnosing systemic lupus erythematosusEXAGEN INC·Filed 2023·Application pending·0 cites
- 1374US7582282B2Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogeneticsPROMETHEUS LAB INC·Filed 2004·Granted Sep 1, 2009·5 cites·28 claims
- 1471US2010203507A1Methods of predicting methotrexate efficacy and toxicityPROMETHEUS LAB INC·Filed 2008·Application pending·0 cites
- 1571US2010203508A1Methods of predicting methotrexate efficacy and toxicityPROMETHEUS LAB INC·Filed 2008·Application pending·0 cites
- 1670US2010159493A1Methods of quantifying methotrexate metabolitesCYPRESS BIOSCIENCE INC·Filed 2009·Application pending·0 cites
- 1767US2021220389A1Methods for diagnosing, prognosing and monitoring treatment for thrombosis in subjects with systemic lupus erythematosusEXAGEN INC·Filed 2021·Application pending·0 cites
- 1866US2013143215A1Methods of Predicting Methotrexate Efficacy and ToxicityPROMETHEUS LAB INC·Filed 2012·Application pending·0 cites
- 1964US2022299510A1Methods for diagnosing, prognosing and monitoring treatment for thrombosis in subjects with systemic lupus erythematosusEXAGEN INC·Filed 2020·Application pending·0 cites
- 2064US2006286571A1Methods of predicting methotrexate efficacy and toxicityPROMETHEUS LAB INC·Filed 2006·Application pending·0 cites
- 2162US2009197267A1Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogeneticsDERVIEUX THIERRY·Filed 2008·Application pending·0 cites
- 2262US2009197268A1Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogeneticsDERVIEUX THIERRY·Filed 2008·Application pending·0 cites
- 2362US2009197266A1Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogeneticsDERVIEUX THIERRY·Filed 2008·Application pending·0 cites
- 2461US7563590B2Methods of quantifying methotrexate metabolitesCYPRESS BIOSCIENCE INC·Filed 2002·Granted Jul 21, 2009·3 cites·32 claims
- 2561US2024395384A1Patient centric precision model for anti-tnf therapyPROMETHEUS LABORATORIES INC·Filed 2022·Application pending·0 cites
- 2658US9822391B2Methods for monitoring methotrexate therapyDERVIEUX THIERRY·Filed 2016·Granted Nov 21, 2017·0 cites·20 claims
- 2758US2024254243A1Systems and methods for improved targeted therapyPROMETHEUS LABORATORIES INC·Filed 2022·Application pending·0 cites
- 2857US2013131072A1Methods for Optimizing Clinical Responsiveness to Methotrexate Therapy Using Metabolite Profiling and PharmacogeneticsDERVIEUX THIERRY·Filed 2013·Application pending·0 cites
- 2953US2011262948A1Methods of Quantifying Methotrexate MetabolitesEXAGEN DIAGNOSTICS INC·Filed 2011·Application pending·0 cites
- 3052US2010203539A1Methods for predicting methotrexate polyglutamate levels using pharmacogeneticsPROMETHEUS LAB INC·Filed 2010·Application pending·0 cites
- 3146US2008268045A1Sustained release methotrexate formulations and methods of use thereofPROPRIUS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3245US2013216530A1Methods for optimizing biological response modifier therapy using therapeutic drug monitoring of immunosuppressantsEXAGEN DIAGNOSTICS INC·Filed 2013·Application pending·0 cites
- 3344US2006216726A1Method for optimizing thiopurine efficacy and toxicity using mass spectrometryPROMETHEUS LAB INC·Filed 2005·Application pending·0 cites
- 3436US2011177531A1Cell-Based Complement Activation Product Algorithm for Diagnosing Systemic Lupus ErythematosusEXAGEN DIAGNOSTICS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thierry Dervieux files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →